KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Return on Assets (2016 - 2025)

Novavax has reported Return on Assets over the past 15 years, most recently at 0.37% for Q4 2025.

  • Quarterly results put Return on Assets at 0.37% for Q4 2025, up 49.0% from a year ago — trailing twelve months through Dec 2025 was 0.37% (up 49.0% YoY), and the annual figure for FY2025 was 0.32%, up 43.0%.
  • Return on Assets for Q4 2025 was 0.37% at Novavax, up from 0.27% in the prior quarter.
  • Over the last five years, Return on Assets for NVAX hit a ceiling of 0.37% in Q4 2025 and a floor of 0.68% in Q4 2021.
  • Median Return on Assets over the past 5 years was 0.3% (2021), compared with a mean of 0.23%.
  • Biggest five-year swings in Return on Assets: plummeted -35bps in 2021 and later skyrocketed 59bps in 2025.
  • Novavax's Return on Assets stood at 0.68% in 2021, then soared by 57bps to 0.29% in 2022, then fell by -9bps to 0.32% in 2023, then soared by 64bps to 0.11% in 2024, then soared by 426bps to 0.37% in 2025.
  • The last three reported values for Return on Assets were 0.37% (Q4 2025), 0.27% (Q3 2025), and 0.32% (Q2 2025) per Business Quant data.